Literature DB >> 11345195

Structural and functional hot spots in cytokine receptors.

C J Bagley1, J M Woodcock, M A Guthridge, F C Stomski, A F Lopez.   

Abstract

The activation of cytokine receptors is a stepwise process that depends on their specific interaction with cognate cytokines, the formation of oligomeric receptor complexes, and the initiation of cytoplasmic phosphorylation events. The recent determination of the structure of extracellular domains of several cytokine receptors allows comparison of their cytokine-binding surfaces. This comparison reveals a common structural framework that supports considerable diversity and adaptability of the binding surfaces that determine both the specificity and the orientation of subunits in the active receptor complex. These regions of the cytokine receptors have been targeted for the development of specific agonists and antagonists. The physical coupling of signaling intermediates to the intracellular domains of their receptors plays a major role in determining biological responses to cytokines. In this review, we focus principally on the receptors for cytokines of the granulocyte-macrophage colony-stimulating factor (GM-CSF) family and, where appropriate, compare them with related cytokine receptors. Several paradigms are beginning to emerge that focus on the ability of the extracellular portion of the cytokine receptor to recognize the appropriate cytokine and on a phosphorylated motif in the intracellular region of the GM-CSF receptor that couples to a specific signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11345195     DOI: 10.1007/BF02981954

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  66 in total

1.  The solution structure of the cytokine-binding domain of the common beta-chain of the receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3 and interleukin-5.

Authors:  T D Mulhern; A F Lopez; R J D'Andrea; C Gaunt; L Vandeleur; M A Vadas; G W Booker; C J Bagley
Journal:  J Mol Biol       Date:  2000-04-07       Impact factor: 5.469

Review 2.  Receptor recognition by gp130 cytokines.

Authors:  J Bravo; J K Heath
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

3.  Rational design of potent antagonists to the human growth hormone receptor.

Authors:  G Fuh; B C Cunningham; R Fukunaga; S Nagata; D V Goeddel; J A Wells
Journal:  Science       Date:  1992-06-19       Impact factor: 47.728

Review 4.  Structure and function of phosphoinositide 3-kinases.

Authors:  M P Wymann; L Pirola
Journal:  Biochim Biophys Acta       Date:  1998-12-08

5.  Cloning of p97/Gab2, the major SHP2-binding protein in hematopoietic cells, reveals a novel pathway for cytokine-induced gene activation.

Authors:  H Gu; J C Pratt; S J Burakoff; B G Neel
Journal:  Mol Cell       Date:  1998-12       Impact factor: 17.970

6.  Simultaneous antagonism of interleukin-5, granulocyte-macrophage colony-stimulating factor, and interleukin-3 stimulation of human eosinophils by targetting the common cytokine binding site of their receptors.

Authors:  Q Sun; K Jones; B McClure; B Cambareri; B Zacharakis; P O Iversen; F Stomski; J M Woodcock; C J Bagley; R D'Andrea; A F Lopez
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

7.  Site-specific serine phosphorylation of the IL-3 receptor is required for hemopoietic cell survival.

Authors:  M A Guthridge; F C Stomski; E F Barry; W Winnall; J M Woodcock; B J McClure; M Dottore; M C Berndt; A F Lopez
Journal:  Mol Cell       Date:  2000-07       Impact factor: 17.970

8.  Human interleukin-3 (IL-3) induces disulfide-linked IL-3 receptor alpha- and beta-chain heterodimerization, which is required for receptor activation but not high-affinity binding.

Authors:  F C Stomski; Q Sun; C J Bagley; J Woodcock; G Goodall; R K Andrews; M C Berndt; A F Lopez
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

9.  Identification of receptor-binding domains on human interleukin 5 and design of an interleukin 5-derived receptor antagonist.

Authors:  J Tavernier; T Tuypens; A Verhee; G Plaetinck; R Devos; J Van der Heyden; Y Guisez; C Oefner
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

10.  A sequential dimerization mechanism for erythropoietin receptor activation.

Authors:  D J Matthews; R S Topping; R T Cass; L B Giebel
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

View more
  1 in total

1.  Codon-based tests of positive selection, branch lengths, and the evolution of mammalian immune system genes.

Authors:  Austin L Hughes; Robert Friedman
Journal:  Immunogenetics       Date:  2008-06-26       Impact factor: 2.846

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.